BACKGROUND:Irritable bowel syndrome (IBS) is a chronic and debilitating medical condition with few efficacious pharmacological or psychosocial treatment options available. Evidence suggests that visceral anxiety may be implicated in IBS onset and severity. Thus, cognitive-behavioral treatment (CBT) that targets visceral anxiety may alleviate IBS symptoms. METHODS: The current study examined the efficacy of a CBT protocol for the treatment of IBS which directly targeted visceral sensations. Participants (N = 110) were randomized to receive 10 sessions of either: (a) CBT with interoceptive exposure (IE) to visceral sensations; (b) stress management (SM); or (c) an attention control (AC), and were assessed at baseline, mid-treatment, post-treatment, and follow-up sessions. RESULTS: Consistent with hypotheses, the IE group outperformed AC on several indices of outcome, and outperformed SM in some domains. No differences were observed between SM and AC. The results suggest that IE may be a particularly efficacious treatment for IBS. CONCLUSIONS: Implications for research and clinical practice are discussed.
RCT Entities:
BACKGROUND:Irritable bowel syndrome (IBS) is a chronic and debilitating medical condition with few efficacious pharmacological or psychosocial treatment options available. Evidence suggests that visceral anxiety may be implicated in IBS onset and severity. Thus, cognitive-behavioral treatment (CBT) that targets visceral anxiety may alleviate IBS symptoms. METHODS: The current study examined the efficacy of a CBT protocol for the treatment of IBS which directly targeted visceral sensations. Participants (N = 110) were randomized to receive 10 sessions of either: (a) CBT with interoceptive exposure (IE) to visceral sensations; (b) stress management (SM); or (c) an attention control (AC), and were assessed at baseline, mid-treatment, post-treatment, and follow-up sessions. RESULTS: Consistent with hypotheses, the IE group outperformed AC on several indices of outcome, and outperformed SM in some domains. No differences were observed between SM and AC. The results suggest that IE may be a particularly efficacious treatment for IBS. CONCLUSIONS: Implications for research and clinical practice are discussed.
Authors: Lawrence J Brandt; David Bjorkman; M Brian Fennerty; G Richard Locke; Kevin Olden; Walter Peterson; Eamonn Quigley; Philip Schoenfeld; Marvin Schuster; Nicholas Talley Journal: Am J Gastroenterol Date: 2002-11 Impact factor: 10.864
Authors: Olafur S Palsson; Marsha J Turner; David A Johnson; Charles K Burnett; William E Whitehead Journal: Dig Dis Sci Date: 2002-11 Impact factor: 3.199
Authors: Douglas A Drossman; Brenda B Toner; William E Whitehead; Nicholas E Diamant; Chris B Dalton; Susan Duncan; Shelagh Emmott; Valerie Proffitt; Donna Akman; Karen Frusciante; Terry Le; Kim Meyer; Barbara Bradshaw; Kristi Mikula; Carolyn B Morris; Carlar J Blackman; Yuming Hu; Huanguang Jia; Jim Z Li; Gary G Koch; Shrikant I Bangdiwala Journal: Gastroenterology Date: 2003-07 Impact factor: 22.682
Authors: Francis Creed; Lakshmi Fernandes; Elspeth Guthrie; Stephen Palmer; Joy Ratcliffe; Nicholas Read; Christine Rigby; David Thompson; Barbara Tomenson Journal: Gastroenterology Date: 2003-02 Impact factor: 22.682
Authors: George F Longstreth; Alisa Wilson; Kevin Knight; John Wong; Chiun-Fang Chiou; Victoria Barghout; Feride Frech; Joshua J Ofman Journal: Am J Gastroenterol Date: 2003-03 Impact factor: 10.864
Authors: Holly Hazlett-Stevens; Michelle G Craske; Emeran A Mayer; Lin Chang; Bruce D Naliboff Journal: J Psychosom Res Date: 2003-12 Impact factor: 3.006
Authors: J Labus; A Gupta; H K Gill; I Posserud; M Mayer; H Raeen; R Bolus; M Simren; B D Naliboff; E A Mayer Journal: Aliment Pharmacol Ther Date: 2012-12-03 Impact factor: 8.171